{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:34:18Z","timestamp":1787891658204,"version":"build-2784847793"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["643476"],"award-info":[{"award-number":["643476"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pandemics and major outbreaks have the potential to cause large health losses and major economic costs. To prioritize between preventive and responsive interventions, it is important to understand the costs and health losses interventions may prevent. We review the literature, investigating the type of studies performed, the costs and benefits included, and the methods employed against perceived major outbreak threats. We searched PubMed and SCOPUS for studies concerning the outbreaks of SARS in 2003, H5N1 in 2003, H1N1 in 2009, Cholera in Haiti in 2010, MERS-CoV in 2013, H7N9 in 2013, and Ebola in West-Africa in 2014. We screened titles and abstracts of papers, and subsequently examined remaining full-text papers. Data were extracted according to a pre-constructed protocol. We included 34 studies of which the majority evaluated interventions related to the H1N1 outbreak in a high-income setting. Most interventions concerned pharmaceuticals. Included costs and benefits, as well as the methods applied, varied substantially between studies. Most studies used a short time horizon and did not include future costs and benefits. We found substantial variation in the included elements and methods used. Policymakers need to be aware of this and the bias toward high-income countries and pharmaceutical interventions, which hampers generalizability. More standardization of included elements, methodology, and reporting would improve economic evaluations and their usefulness for policy.<\/jats:p>","DOI":"10.1007\/s10198-020-01218-4","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T15:49:59Z","timestamp":1597333799000},"page":"1329-1350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-2847","authenticated-orcid":false,"given":"Klas","family":"Kellerborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"van Baal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"1218_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1353\/bhm.2002.0022","volume":"76","author":"NPAS Johnson","year":"2002","unstructured":"Johnson, N.P.A.S., Mueller, J.: Updating the accounts: global mortality of the 1918\u20131920 \u201cSpanish\u201d influenza pandemic. Bull. Hist. Med. 76, 105\u2013115 (2002)","journal-title":"Bull. Hist. Med."},{"key":"1218_CR2","doi-asserted-by":"publisher","first-page":"20140950","DOI":"10.1098\/rsif.2014.0950","volume":"11","author":"KF Smith","year":"2014","unstructured":"Smith, K.F., Goldberg, M., Rosenthal, S., Carlson, L., Chen, J., Chen, C., et al.: Global rise in human infectious disease outbreaks. J. R. Soc. Interface 11, 20140950 (2014)","journal-title":"J. R. Soc. Interface"},{"key":"1218_CR3","volume-title":"International Health Regulations, (2005)","author":"The Organization","year":"2008","unstructured":"The Organization: International Health Regulations, (2005), 2nd edn. The Organization, Geneva (2008)","edition":"2"},{"key":"1218_CR4","doi-asserted-by":"publisher","first-page":"E377","DOI":"10.1503\/cmaj.109-5125","volume":"187","author":"S Lough","year":"2015","unstructured":"Lough, S.: Lessons from Ebola bring WHO reforms. CMAJ 187, E377\u2013E378 (2015). https:\/\/doi.org\/10.1503\/cmaj.109-5125","journal-title":"CMAJ"},{"key":"1218_CR5","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond, M.F., Sculpher, M.J., Claxton, K., Stoddart, G.L., Torrance, G.W.: Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, Oxford (2015)"},{"key":"1218_CR6","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-Effectiveness in Health and Medicine: Report of the Panel on Cost-effectiveness in Health and Medicine","author":"MR Gold","year":"1996","unstructured":"Gold, M.R., Siegel, J.E., Russell, L.B., Weinstein, M.C.: Cost-Effectiveness in Health and Medicine: Report of the Panel on Cost-effectiveness in Health and Medicine. Oxford Univ Pr, New York (1996)"},{"key":"1218_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1204","author":"M Drummond","year":"2008","unstructured":"Drummond, M., Weatherly, H., Ferguson, B.: Economic evaluation of health interventions. BMJ (2008). https:\/\/doi.org\/10.1136\/bmj.a1204","journal-title":"BMJ"},{"key":"1218_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hec.1339","volume":"17","author":"P Beutels","year":"2008","unstructured":"Beutels, P., Edmunds, W.J., Smith, R.D.: Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern. Health Econ. 17, 1317\u20131322 (2008). https:\/\/doi.org\/10.1002\/hec.1339","journal-title":"Health Econ."},{"key":"1218_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10198-009-0210-1","volume":"11","author":"MR Keogh-Brown","year":"2010","unstructured":"Keogh-Brown, M.R., Smith, R.D., Edmunds, J.W., Beutels, P.: The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands. Eur J Health Econ 11, 543\u2013554 (2010). https:\/\/doi.org\/10.1007\/s10198-009-0210-1","journal-title":"Eur J Health Econ"},{"key":"1218_CR10","volume-title":"Infectious Diseases of Humans: Dynamics and Control","author":"RM Anderson","year":"1992","unstructured":"Anderson, R.M., May, R.M.: Infectious Diseases of Humans: Dynamics and Control. OUP, Oxford (1992)"},{"key":"1218_CR11","volume-title":"An Introduction to Infectious Disease Modelling","author":"E Vynnycky","year":"2010","unstructured":"Vynnycky, E., White, R.: An Introduction to Infectious Disease Modelling. OUP, Oxford (2010)"},{"key":"1218_CR12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jval.2012.06.011","volume":"15","author":"R Pitman","year":"2012","unstructured":"Pitman, R., Fisman, D., Zaric, G.S., Postma, M., Kretzschmar, M., Edmunds, J., et al.: Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20135. Value Heal. J. Int. Soc. Pharmacoecon. Outcomes Res. 15, 828\u2013834 (2012). https:\/\/doi.org\/10.1016\/j.jval.2012.06.011","journal-title":"Value Heal. J. Int. Soc. Pharmacoecon. Outcomes Res."},{"key":"1218_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.epidem.2014.09.005","volume":"10","author":"S Funk","year":"2015","unstructured":"Funk, S., Bansal, S., Bauch, C.T., Eames, K.T.D., Edmunds, W.J., Galvani, A.P., et al.: Nine challenges in incorporating the dynamics of behaviour in infectious diseases models. Epidemics 10, 21\u201325 (2015). https:\/\/doi.org\/10.1016\/j.epidem.2014.09.005","journal-title":"Epidemics"},{"key":"1218_CR14","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2471\/BLT.12.109025","volume":"90","author":"TL Drake","year":"2012","unstructured":"Drake, T.L., Chalabi, Z., Coker, R.: Cost-effectiveness analysis of pandemic influenza preparedness: what\u2019s missing? Bull. World Health Organ. 90, 940\u2013941 (2012). https:\/\/doi.org\/10.2471\/BLT.12.109025","journal-title":"Bull. World Health Organ."},{"key":"1218_CR15","doi-asserted-by":"publisher","DOI":"10.3386\/w7037","volume-title":"Economic Epidemiology and Infectious Diseases","author":"T Philipson","year":"1999","unstructured":"Philipson, T.: Economic Epidemiology and Infectious Diseases. National Bureau of Economic Research, Cambridge (1999)"},{"key":"1218_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jhealeco.2016.06.001","volume":"49","author":"A Morton","year":"2016","unstructured":"Morton, A., Thomas, R., Smith, P.C.: Decision rules for allocation of finances to health systems strengthening. J Health Econ 49, 97\u2013108 (2016). https:\/\/doi.org\/10.1016\/j.jhealeco.2016.06.001","journal-title":"J Health Econ"},{"key":"1218_CR17","unstructured":"World Health Organization. Infographics: major infectious threats in the 21st Century & collaboration mechanisms to fight against them (2017)"},{"key":"1218_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.bpg.2013.08.017","volume":"27","author":"GM Ginsberg","year":"2013","unstructured":"Ginsberg, G.M.: Generalizability of cost-utility analyses across countries and settings. Best Pract. Res. Clin. Gastroenterol. 27, 845\u2013852 (2013). https:\/\/doi.org\/10.1016\/j.bpg.2013.08.017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"1218_CR19","unstructured":"World Bank. World Bank Country and Lending Groups\u2014World Bank Data Help Desk n.d. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519. Accessed 25 Oct 2018"},{"key":"1218_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/hec.3138","volume":"25","author":"P van Baal","year":"2016","unstructured":"van Baal, P., Meltzer, D., Brouwer, W.: Future costs, fixed healthcare budgets, and the decision rules of cost-effectiveness analysis. Health Econ. 25, 237\u2013248 (2016). https:\/\/doi.org\/10.1002\/hec.3138","journal-title":"Health Econ."},{"key":"1218_CR21","volume-title":"Economic Evaluation in Health Care: Merging Theory with Practice","author":"WBF Brouwer","year":"2001","unstructured":"Brouwer, W.B.F., Rutten, F.F.H.K.M.: Costing in economic evaluations. In: Drummond, M.F., McGuire, A. (eds.) Economic Evaluation in Health Care: Merging Theory with Practice. Oxford University Press, New York (2001)"},{"key":"1218_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0167-6296(94)00044-5","volume":"14","author":"MA Koopmanschap","year":"1995","unstructured":"Koopmanschap, M.A., Rutten, F.F., van Ineveld, B.M., van Roijen, L.: The friction cost method for measuring indirect costs of disease. J. Health Econ. 14, 171\u2013189 (1995)","journal-title":"J. Health Econ."},{"key":"1218_CR23","first-page":"j5086","volume":"359","author":"P van Baal","year":"2017","unstructured":"van Baal, P., Morton, A., Brouwer, W., Meltzer, D., Davis, S.: Should cost effectiveness analyses for NICE always consider future unrelated medical costs? BMJ 359, j5086 (2017)","journal-title":"BMJ"},{"key":"1218_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0167-6296(96)00507-3","volume":"16","author":"D Meltzer","year":"1997","unstructured":"Meltzer, D.: Accounting for future costs in medical cost-effectiveness analysis. J. Health Econ. 16, 33\u201364 (1997)","journal-title":"J. Health Econ."},{"key":"1218_CR25","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1097\/MLR.0b013e31819e1f3f","volume":"47","author":"PG Barnett","year":"2009","unstructured":"Barnett, P.G.: An improved set of standards for finding cost for cost-effectiveness analysis. Med. Care 47, S82\u2013S88 (2009). https:\/\/doi.org\/10.1097\/MLR.0b013e31819e1f3f","journal-title":"Med. Care"},{"key":"1218_CR26","volume-title":"Making Choices in Health: WHO Guide to Cost-effectiveness Analysis","author":"R Baltussen","year":"2004","unstructured":"Baltussen, R., Taghreed, A., Torres, T.T., Hutubessy, R., Acharya, A., Evans, D.B., et al.: Making Choices in Health: WHO Guide to Cost-effectiveness Analysis. WHO, Geneva (2004)"},{"key":"1218_CR27","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.vaccine.2010.12.078","volume":"29","author":"BY Lee","year":"2011","unstructured":"Lee, B.Y., Bacon, K.M., Donohue, J.M., Wiringa, A.E., Bailey, R.R., Zimmerman, R.K.: From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine 29, 2149\u20132158 (2011). https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.078","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"1218_CR28","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2458-11-S1-S1","volume":"11","author":"S Andradottir","year":"2011","unstructured":"Andradottir, S., Chiu, W., Goldsman, D., Lee, M.L., Tsui, K.-L., Sander, B., et al.: Reactive strategies for containing developing outbreaks of pandemic influenza. BMC Public Health 11(Suppl 1), S1 (2011). https:\/\/doi.org\/10.1186\/1471-2458-11-S1-S1","journal-title":"BMC Public Health"},{"key":"1218_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/PEC.0b013e318248b266","volume":"28","author":"J Pershad","year":"2012","unstructured":"Pershad, J., Waters, T.M.: Use of tent for screening during H1N1 pandemic: impact on quality and cost of care. Pediatr. Emerg. Care 28, 229\u2013235 (2012). https:\/\/doi.org\/10.1097\/PEC.0b013e318248b266","journal-title":"Pediatr. Emerg. Care"},{"key":"1218_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.vaccine.2017.12.058","volume":"36","author":"S Tsuzuki","year":"2018","unstructured":"Tsuzuki, S., Schwehm, M., Eichner, M.: Simulation studies to assess the long-term effects of Japan\u2019s change from trivalent to quadrivalent influenza vaccination. Vaccine 36, 624\u2013630 (2018). https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.058","journal-title":"Vaccine"},{"key":"1218_CR31","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1017\/S0950268815003003","volume":"144","author":"JY Wong","year":"2016","unstructured":"Wong, J.Y., Zhang, W., Kargbo, D., Haque, U., Hu, W., Wu, P., et al.: Assessment of the severity of Ebola virus disease in Sierra Leone in 2014\u20132015. Epidemiol Infect 144, 1473\u20131481 (2016). https:\/\/doi.org\/10.1017\/S0950268815003003","journal-title":"Epidemiol Infect"},{"key":"1218_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12913-015-1169-5","volume":"15","author":"B-K Yoo","year":"2015","unstructured":"Yoo, B.-K., Humiston, S.G., Szilagyi, P.G., Schaffer, S.J., Long, C., Kolasa, M.: Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial. BMC Health Serv. Res. 15, 511 (2015). https:\/\/doi.org\/10.1186\/s12913-015-1169-5","journal-title":"BMC Health Serv. Res."},{"key":"1218_CR33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jinf.2004.08.006","volume":"50","author":"AG Gupta","year":"2005","unstructured":"Gupta, A.G., Moyer, C.A., Stern, D.T.: The economic impact of quarantine: SARS in Toronto as a case study. J. Infect. 50, 386\u2013393 (2005). https:\/\/doi.org\/10.1016\/j.jinf.2004.08.006","journal-title":"J. Infect."},{"key":"1218_CR34","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3201\/eid1708.101546","volume":"17","author":"NV Mota","year":"2011","unstructured":"Mota, N.V., Lobo, R.D., Toscano, C.M., de Lima, A.C.P., Souza Dias, M.B., Komagata, H., et al.: Cost-effectiveness of sick leave policies for health care workers with influenza-like illness, Brazil, 2009. Emerg Infect Dis 17, 1421\u20131429 (2011). https:\/\/doi.org\/10.3201\/eid1708.101546","journal-title":"Emerg Infect Dis"},{"key":"1218_CR35","first-page":"19333","volume":"14","author":"L Brouwers","year":"2009","unstructured":"Brouwers, L., Cakici, B., Camitz, M., Tegnell, A., Boman, M.: Economic consequences to society of pandemic H1N1 influenza 2009\u2014preliminary results for Sweden. Euro Surveill Bull Eur Sur Les Mal Transm Eur Commun Dis Bull 14, 19333 (2009)","journal-title":"Euro Surveill Bull Eur Sur Les Mal Transm Eur Commun Dis Bull"},{"key":"1218_CR36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1473-3099(15)00465-X","volume":"16","author":"C Carias","year":"2016","unstructured":"Carias, C., Junior, B.G., Campbell, C.G., Meltzer, M.I., Hamel, M.J.: Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014\u201315 Ebola virus disease response: an economic analysis. Lancet Infect Dis 16, 449\u2013458 (2016). https:\/\/doi.org\/10.1016\/S1473-3099(15)00465-X","journal-title":"Lancet Infect Dis"},{"key":"1218_CR37","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3201\/eid1512.090902","volume":"15","author":"YY Dan","year":"2009","unstructured":"Dan, Y.Y., Tambyah, P.A., Sim, J., Lim, J., Hsu, L.Y., Chow, W.L., et al.: Cost-effectiveness analysis of hospital infection control response to an epidemic respiratory virus threat. Emerg. Infect. Dis. 15, 1909\u20131916 (2009). https:\/\/doi.org\/10.3201\/eid1512.090902","journal-title":"Emerg. Infect. Dis."},{"key":"1218_CR38","doi-asserted-by":"publisher","first-page":"e22087","DOI":"10.1371\/journal.pone.0022087","volume":"6","author":"N Halder","year":"2011","unstructured":"Halder, N., Kelso, J.K., Milne, G.J.: Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics. PLoS One 6, e22087 (2011). https:\/\/doi.org\/10.1371\/journal.pone.0022087","journal-title":"PLoS One"},{"key":"1218_CR39","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1186\/s12889-016-3297-1","volume":"16","author":"A Jamotte","year":"2016","unstructured":"Jamotte, A., Chong, C.F., Manton, A., Macabeo, B., Toumi, M.: Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia. BMC Public Health 16, 630 (2016). https:\/\/doi.org\/10.1186\/s12889-016-3297-1","journal-title":"BMC Public Health"},{"key":"1218_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/1471-2458-13-211","volume":"13","author":"JK Kelso","year":"2013","unstructured":"Kelso, J.K., Halder, N., Postma, M.J., Milne, G.J.: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories. BMC Public Health 13, 211 (2013). https:\/\/doi.org\/10.1186\/1471-2458-13-211","journal-title":"BMC Public Health"},{"key":"1218_CR41","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.3390\/ijerph10104690","volume":"10","author":"X Li","year":"2013","unstructured":"Li, X., Geng, W., Tian, H., Lai, D.: Was mandatory quarantine necessary in China for controlling the 2009 H1N1 pandemic? Int. J. Environ. Res. Public Health 10, 4690\u20134700 (2013). https:\/\/doi.org\/10.3390\/ijerph10104690","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"1218_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1742-4682-11-5","volume":"11","author":"H Nishiura","year":"2014","unstructured":"Nishiura, H., Ejima, K., Mizumoto, K., Nakaoka, S., Inaba, H., Imoto, S., et al.: Cost-effective length and timing of school closure during an influenza pandemic depend on the severity. Theor. Biol. Med. Model. 11, 5 (2014). https:\/\/doi.org\/10.1186\/1742-4682-11-5","journal-title":"Theor. Biol. Med. Model."},{"key":"1218_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/1471-2458-12-449","volume":"12","author":"OM Araz","year":"2012","unstructured":"Araz, O.M., Damien, P., Paltiel, D.A., Burke, S., van de Geijn, B., Galvani, A., et al.: Simulating school closure policies for cost effective pandemic decision making. BMC Public Health 12, 449 (2012). https:\/\/doi.org\/10.1186\/1471-2458-12-449","journal-title":"BMC Public Health"},{"key":"1218_CR44","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1086\/649013","volume":"49","author":"RH Beigi","year":"2009","unstructured":"Beigi, R.H., Wiringa, A.E., Bailey, R.R., Assi, T.-M., Lee, B.Y.: Economic value of seasonal and pandemic influenza vaccination during pregnancy. Clin. Infect. Dis. 49, 1784\u20131792 (2009). https:\/\/doi.org\/10.1086\/649013","journal-title":"Clin. Infect. Dis."},{"key":"1218_CR45","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1186\/1471-2458-12-962","volume":"12","author":"Y Xue","year":"2012","unstructured":"Xue, Y., Kristiansen, I.S., de Blasio, B.F.: Dynamic modelling of costs and health consequences of school closure during an influenza pandemic. BMC Public Health 12, 962 (2012). https:\/\/doi.org\/10.1186\/1471-2458-12-962","journal-title":"BMC Public Health"},{"key":"1218_CR46","doi-asserted-by":"publisher","first-page":"e33123","DOI":"10.1371\/journal.pone.0033123","volume":"7","author":"JHS You","year":"2012","unstructured":"You, J.H.S., Chan, E.S.K., Leung, M.Y.K., Ip, M., Lee, N.L.S.: A cost-effectiveness analysis of \u201ctest\u201d versus \u201ctreat\u201d patients hospitalized with suspected influenza in Hong Kong. PLoS One 7, e33123 (2012). https:\/\/doi.org\/10.1371\/journal.pone.0033123","journal-title":"PLoS One"},{"key":"1218_CR47","doi-asserted-by":"publisher","first-page":"e22308","DOI":"10.1371\/journal.pone.0022308","volume":"6","author":"LA Prosser","year":"2011","unstructured":"Prosser, L.A., Lavelle, T.A., Fiore, A.E., Bridges, C.B., Reed, C., Jain, S., et al.: Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. PLoS One 6, e22308 (2011). https:\/\/doi.org\/10.1371\/journal.pone.0022308","journal-title":"PLoS One"},{"key":"1218_CR48","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4161\/hv.18569","volume":"8","author":"N Giglio","year":"2012","unstructured":"Giglio, N., Gentile, A., Lees, L., Micone, P., Armoni, J., Reygrobellet, C., et al.: Public health and economic benefits of new pediatric influenza vaccination programs in Argentina. Hum. Vaccin. Immunother. 8, 312\u2013322 (2012). https:\/\/doi.org\/10.4161\/hv.18569","journal-title":"Hum. Vaccin. Immunother."},{"key":"1218_CR49","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1016\/j.vaccine.2007.09.018","volume":"25","author":"CL Hibbert","year":"2007","unstructured":"Hibbert, C.L., Piedra, P.A., McLaurin, K.K., Vesikari, T., Mauskopf, J., Mahadevia, P.J.: Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine 25, 8010\u20138020 (2007). https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.018","journal-title":"Vaccine"},{"key":"1218_CR50","doi-asserted-by":"publisher","first-page":"829","DOI":"10.7326\/0003-4819-151-12-200912150-00157","volume":"151","author":"N Khazeni","year":"2009","unstructured":"Khazeni, N., Hutton, D.W., Garber, A.M., Hupert, N., Owens, D.K.: Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann. Intern. Med. 151, 829\u2013839 (2009). https:\/\/doi.org\/10.7326\/0003-4819-151-12-200912150-00157","journal-title":"Ann. Intern. Med."},{"key":"1218_CR51","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/M13-2071","volume":"160","author":"N Khazeni","year":"2014","unstructured":"Khazeni, N., Hutton, D.W., Collins, C.I.F., Garber, A.M., Owens, D.K.: Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study. Ann. Intern. Med. 160, 684\u2013694 (2014). https:\/\/doi.org\/10.7326\/M13-2071","journal-title":"Ann. Intern. Med."},{"key":"1218_CR52","doi-asserted-by":"publisher","first-page":"840","DOI":"10.7326\/0003-4819-151-12-200912150-00156","volume":"151","author":"N Khazeni","year":"2009","unstructured":"Khazeni, N., Hutton, D.W., Garber, A.M., Owens, D.K.: Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann. Intern. Med. 151, 840\u2013853 (2009). https:\/\/doi.org\/10.7326\/0003-4819-151-12-200912150-00156","journal-title":"Ann. Intern. Med."},{"key":"1218_CR53","first-page":"e1","volume":"17","author":"BY Lee","year":"2011","unstructured":"Lee, B.Y., Tai, J.H.Y., Bailey, R.R., McGlone, S.M., Wiringa, A.E., Zimmer, S.M., et al.: Economic model for emergency use authorization of intravenous peramivir. Am. J. Manag. Care 17, e1\u2013e9 (2011)","journal-title":"Am. J. Manag. Care"},{"key":"1218_CR54","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1471-2334-13-229","volume":"13","author":"LJ McGarry","year":"2013","unstructured":"McGarry, L.J., Gilmore, K.E., Rubin, J.L., Klugman, K.P., Strutton, D.R., Weinstein, M.C.: Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States. BMC Infect. Dis. 13, 229 (2013). https:\/\/doi.org\/10.1186\/1471-2334-13-229","journal-title":"BMC Infect. Dis."},{"key":"1218_CR55","doi-asserted-by":"publisher","first-page":"6210","DOI":"10.1016\/j.vaccine.2010.07.010","volume":"28","author":"B Sander","year":"2010","unstructured":"Sander, B., Bauch, C.T., Fisman, D., Fowler, R.A., Kwong, J.C., Maetzel, A., et al.: Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian experience. Vaccine 28, 6210\u20136220 (2010). https:\/\/doi.org\/10.1016\/j.vaccine.2010.07.010","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"1218_CR56","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1111\/1475-6773.12786","volume":"52","author":"R Basurto-Davila","year":"2017","unstructured":"Basurto-Davila, R., Meltzer, M.I., Mills, D.A., Beeler Asay, G.R., Cho, B.-H., Graitcer, S.B., et al.: School-based influenza vaccination: health and economic impact of maine\u2019s 2009 influenza vaccination program. Health Serv. Res. 52(Suppl 2), 2307\u20132330 (2017). https:\/\/doi.org\/10.1111\/1475-6773.12786","journal-title":"Health Serv. Res."},{"key":"1218_CR57","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/1471-2458-11-353","volume":"11","author":"ST Brown","year":"2011","unstructured":"Brown, S.T., Tai, J.H.Y., Bailey, R.R., Cooley, P.C., Wheaton, W.D., Potter, M.A., et al.: Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania. BMC Public Health 11, 353 (2011). https:\/\/doi.org\/10.1186\/1471-2458-11-353","journal-title":"BMC Public Health"},{"key":"1218_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.healthpol.2012.10.013","volume":"109","author":"M Mamma","year":"2013","unstructured":"Mamma, M., Spandidos, D.A.: Economic evaluation of the vaccination program against seasonal and pandemic A\/H1N1 influenza among customs officers in Greece. Health Policy 109, 71\u201377 (2013). https:\/\/doi.org\/10.1016\/j.healthpol.2012.10.013","journal-title":"Health Policy"},{"key":"1218_CR59","first-page":"34","volume":"41","author":"B Wang","year":"2012","unstructured":"Wang, B., Xie, J., Fang, P.: Is a mass prevention and control program for pandemic (H1N1) 2009 good value for money? Evidence from the Chinese experience. Iran J. Public Health 41, 34\u201343 (2012)","journal-title":"Iran J. Public Health"},{"key":"1218_CR60","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jtbi.2012.01.032","volume":"300","author":"SM Tracht","year":"2012","unstructured":"Tracht, S.M., Del Valle, S.Y., Edwards, B.K.: Economic analysis of the use of facemasks during pandemic (H1N1) 2009. J. Theor. Biol. 300, 161\u2013172 (2012). https:\/\/doi.org\/10.1016\/j.jtbi.2012.01.032","journal-title":"J. Theor. Biol."},{"issue":"11","key":"1218_CR61","doi-asserted-by":"publisher","first-page":"e0147052","DOI":"10.1371\/journal.pone.0147052","volume":"2016","author":"ZS-Y Wong","year":"2009","unstructured":"Wong, Z.S.-Y., Goldsman, D., Tsui, K.-L.: Economic evaluation of individual school closure strategies: the Hong Kong 2009 H1N1 pandemic. PLoS One 2016(11), e0147052 (2009). https:\/\/doi.org\/10.1371\/journal.pone.0147052","journal-title":"PLoS One"},{"key":"1218_CR62","doi-asserted-by":"publisher","first-page":"e30333","DOI":"10.1371\/journal.pone.0030333","volume":"7","author":"R Perez Velasco","year":"2012","unstructured":"Perez Velasco, R., Praditsitthikorn, N., Wichmann, K., Mohara, A., Kotirum, S., Tantivess, S., et al.: Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics. PLoS One 7, e30333 (2012). https:\/\/doi.org\/10.1371\/journal.pone.0030333","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"1218_CR63","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/hec.3303","volume":"25","author":"TL Drake","year":"2016","unstructured":"Drake, T.L., Devine, A., Yeung, S., Day, N.P.J., White, L.J., Lubell, Y.: Dynamic transmission economic evaluation of infectious disease interventions in low- and middle-income countries: a systematic literature review. Health Econ. 25(Suppl 1), 124\u2013139 (2016). https:\/\/doi.org\/10.1002\/hec.3303","journal-title":"Health Econ."},{"key":"1218_CR64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.socscimed.2018.01.026","volume":"200","author":"P van Baal","year":"2018","unstructured":"van Baal, P., Morton, A., Severens, J.L.: Health care input constraints and cost effectiveness analysis decision rules. Soc. Sci. Med. 200, 59\u201364 (2018). https:\/\/doi.org\/10.1016\/j.socscimed.2018.01.026","journal-title":"Soc. Sci. Med."},{"key":"1218_CR65","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jval.2012.01.005","volume":"15","author":"TA Westra","year":"2012","unstructured":"Westra, T.A., Parouty, M., Brouwer, W.B., Beutels, P.H., Rogoza, R.M., Rozenbaum, M.H., et al.: On discounting of health gains from human papillomavirus vaccination: effects of different approaches. Value Heal. J. Int. Soc. Pharmacoecon. Outcomes Res. 15, 562\u2013567 (2012). https:\/\/doi.org\/10.1016\/j.jval.2012.01.005","journal-title":"Value Heal. J. Int. Soc. Pharmacoecon. Outcomes Res."},{"key":"1218_CR66","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/hec.1612","volume":"20","author":"K Claxton","year":"2011","unstructured":"Claxton, K., Paulden, M., Gravelle, H., Brouwer, W., Culyer, A.J.: Discounting and decision making in the economic evaluation of health-care technologies. Health Econ. 20, 2\u201315 (2011)","journal-title":"Health Econ."},{"key":"1218_CR67","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s40273-018-0672-z","volume":"36","author":"AE Attema","year":"2018","unstructured":"Attema, A.E., Brouwer, W.B.F., Claxton, K.: Discounting in economic evaluations. Pharmacoeconomics 36, 745\u2013758 (2018). https:\/\/doi.org\/10.1007\/s40273-018-0672-z","journal-title":"Pharmacoeconomics"},{"key":"1218_CR68","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1098\/rsif.2010.0142","volume":"7","author":"S Funk","year":"2010","unstructured":"Funk, S., Salathe, M., Jansen, V.A.A.: Modelling the influence of human behaviour on the spread of infectious diseases: a review. J. R. Soc. Interface 7, 1247\u20131256 (2010). https:\/\/doi.org\/10.1098\/rsif.2010.0142","journal-title":"J. R. Soc. Interface"},{"key":"1218_CR69","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/risa.12625","volume":"37","author":"F Prager","year":"2017","unstructured":"Prager, F., Wei, D., Rose, A.: Total economic consequences of an influenza outbreak in the United States. Risk Anal 37, 4\u201319 (2017). https:\/\/doi.org\/10.1111\/risa.12625","journal-title":"Risk Anal"},{"key":"1218_CR70","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1049","author":"D Husereau","year":"2013","unstructured":"Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., et al.: Consolidated health economic evaluation reporting standards (CHEERS) statement. BMJ (2013). https:\/\/doi.org\/10.1136\/bmj.f1049","journal-title":"BMJ"},{"key":"1218_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0749-8","author":"LM de Vries","year":"2018","unstructured":"de Vries, L.M., van Baal, P.H.M., Brouwer, W.B.F.: Future costs in cost-effectiveness analyses: past, present. Future Pharmacoecon. (2018). https:\/\/doi.org\/10.1007\/s40273-018-0749-8","journal-title":"Future Pharmacoecon."}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-020-01218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-020-01218-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-020-01218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T19:45:47Z","timestamp":1723405547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-020-01218-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1007\/s10198-020-01218-4","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"14 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MSc. Kellerborg reports grants from European Union, during the conduct of the study; Dr. Brouwer reports grants from Consortium pharmaceutical companies, outside the submitted work; Dr. van Baal reports grants from European Union, during the conduct of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}